| Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04 MJ O'Connell, LH Colangelo, RW Beart, NJ Petrelli, CJ Allegra, S Sharif, ... Journal of clinical oncology 32 (18), 1927, 2014 | 495 | 2014 |
| Patterns of failure following curative resection of gastric carcinoma J Landry, JE Tepper, WC Wood, EO Moulton, F Koerner, J Sullinger International Journal of Radiation Oncology* Biology* Physics 19 (6), 1357-1362, 1990 | 374 | 1990 |
| Neoadjuvant 5-FU or capecitabine plus radiation with or without oxaliplatin in rectal cancer patients: a phase III randomized clinical trial CJ Allegra, G Yothers, MJ O’Connell, RW Beart, TF Wozniak, HC Pitot, ... Journal of the National Cancer Institute 107 (11), djv248, 2015 | 349 | 2015 |
| The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04. MS Roh, GA Yothers, MJ O'connell, RW Beart, HC Pitot, AF Shields, ... Journal of Clinical Oncology 29 (15_suppl), 3503-3503, 2011 | 303 | 2011 |
| Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation A Chakravarti, CC Compton, PC Shellito, WC Wood, J Landry, ... Annals of surgery 230 (1), 49, 1999 | 299 | 1999 |
| The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors … BS Hawkins American journal of ophthalmology 138 (6), 936-951, 2004 | 269 | 2004 |
| Modified FOLFIRINOX regimen with improved safety and maintained efficacy in pancreatic adenocarcinoma H Mahaseth, E Brutcher, J Kauh, N Hawk, S Kim, Z Chen, DA Kooby, ... Pancreas 42 (8), 1311-1315, 2013 | 231 | 2013 |
| Histopathologic characteristics of uveal melanomas in eyes enucleated from the collaborative ocular melanoma study COMS Report No. 6 Collaborative Ocular Melanoma Study Group American journal of ophthalmology 125 (6), 745-766, 1998 | 201 | 1998 |
| Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study LR Coia, BD Minsky, BA Berkey, MJ John, D Haller, J Landry, ... Journal of clinical oncology 18 (3), 455-455, 2000 | 184 | 2000 |
| Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5‐fluorouracil, and cisplatin followed by radiotherapy and 5‐fluorouracil for patients with … J Landry, PJ Catalano, C Staley, W Harris, J Hoffman, M Talamonti, N Xu, ... Journal of surgical oncology 101 (7), 587-592, 2010 | 170 | 2010 |
| Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and … JC Landry, GY Yang, JY Ting, CA Staley, W Torres, N Esiashvili, ... Medical Dosimetry 27 (2), 121-129, 2002 | 130 | 2002 |
| Multiple management modalities in esophageal cancer: combined modality management approaches M Koshy, N Esiashvilli, JC Landry, CR Thomas Jr, RH Matthews The oncologist 9 (2), 147-159, 2004 | 129 | 2004 |
| TRAM flap breast reconstruction after radiation treatment JK Williams, J Bostwick III, JT Bried, G Mackay, J Landry, J Benton Annals of surgery 221 (6), 756-766, 1995 | 129 | 1995 |
| Pronecrotic mixed lineage kinase domain‐like protein expression is a prognostic biomarker in patients with early‐stage resected pancreatic adenocarcinoma LE Colbert, SB Fisher, CW Hardy, WA Hall, B Saka, JW Shelton, ... Cancer 119 (17), 3148-3155, 2013 | 127 | 2013 |
| Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation J Zhong, K Patel, J Switchenko, RJ Cassidy, WA Hall, T Gillespie, ... Cancer 123 (18), 3486-3493, 2017 | 122 | 2017 |
| Prognostic accuracy of computed tomography findings for patients with laryngeal cancer undergoing laryngectomy JJ Beitler, S Muller, WJ Grist, A Corey, AM Klein, MM Johns, CL Perkins, ... Journal of clinical oncology 28 (14), 2318-2322, 2010 | 118 | 2010 |
| Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3 PN Ganji, W Park, J Wen, H Mahaseth, J Landry, AB Farris, F Willingham, ... Angiogenesis 16, 903-917, 2013 | 116 | 2013 |
| Multiple management modalities in esophageal cancer: epidemiology, presentation and progression, work-up, and surgical approaches M Koshy, N Esiashvilli, JC Landry, CR Thomas Jr, RH Matthews The oncologist 9 (2), 137-146, 2004 | 116 | 2004 |
| Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer GP Nagaraju, TE Long, W Park, JC Landry, LT Taliaferro‐Smith, AB Farris, ... Molecular carcinogenesis 54 (10), 1147-1158, 2015 | 101 | 2015 |
| Immediate breast reconstruction for stage III breast cancer using transverse rectus abdominis musculocutaneous (TRAM) flap TM Styblo, MM Lewis, GW Carlson, DR Murray, WC Wood, D Lawson, ... Annals of Surgical Oncology 3, 375-380, 1996 | 95 | 1996 |
Jay SheltonAssistant Professor of Radiation Oncology, Emory UniversityVerified email at emory.edu
